Outpatient CAR-T therapy shows promise for treating lymphoma patients

In the largest prospective study to date examining the use of chimeric antigen receptor (CAR)-T therapy in a community setting on an outpatient basis, patients with relapsed or refractory large B-cell lymphoma (LBCL) responded well to treatment with few serious side effects, according to results published today in Blood Advances.

MEDICLIN increases Group sales and Group operating result – Biotech Investments

EQS-News: MediClin AG / Key word(s): 9 Month figures MEDICLIN increases Group sales and Group operating result 03.11.2023 / 14:30 CET/CEST The issuer is solely

November 4, 2023

Medical Tourists Bring Home Fatal Fungal Infections

BOSTON — A number of U.S. individuals who traveled to Matamoros, Mexico, for surgical procedures requiring anesthesia returned home with a fungal pathogen that caused

October 14, 2023

Bicycle Therapeutics Plc Patent: High Affinity Nectin-4 Binders for Disease Treatment

Share this article According to GlobalData’s company profile on Bicycle Therapeutics, Nanoparticle drug conjugates was a key innovation area identified from patents. Bicycle Therapeutics‘s grant

April 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.